Both in Biotechnology
Novavax vs Maze Therapeutics
Over the past year NVAX returned +41.8% and MAZE returned +3.0%; their daily moves had a correlation of 0.18.
NVAX +41.8% MAZE +3.0%Growth of $1, one year, split-adjusted
| Metric | NVAX | MAZE |
|---|---|---|
| Price | $10.65 | $33.38 |
| Market cap | $1.76B | $1.85B |
| Today | +10.02% | +3.50% |
| 1 month | −5.9% | +26.3% |
| 6 months | +13.8% | +26.1% |
| Year to date | +58.5% | −19.4% |
| 1 year | +34.6% | +0.4% |
| Revenue growth (YoY) | −76.3% | — |
| Gross margin | 74.9% | — |
| Net margin | −94.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.2× | 92.7× |
| Net cash | $422.0M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 82.7% | 67.7% |
| Short % of float | 30.3% | 18.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).